Skip to main content
Home

Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE),  American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA). 

RSS icon

  • Shockwave Medical, a Johnson & Johnson MedTech company, has officially launched its Shockwave E8 Peripheral IVL Catheter in the United States. Shockwave’s E8 catheter was designed specifically to treat patients with calcified femoropopliteal and below-the-knee (BTK) peripheral artery disease (PAD), including those diagnosed with complex chronic limb-threatening ischemia (CLTI).

    Peripheral IVL linked to key benefits over atherectomy as utilization increases

    Atherectomy is still the go-to treatment option for many clinicians, but peripheral IVL appears to be gaining momentum as time goes on. 

  • Cara Santillo explains how new CPT codes are expanding reimbursement CCTA AI. #Heartflow #SCCT #YesCCT

    New CPT codes are expanding reimbursement for AI-powered CCTA tools

    New codes for these technologies have made a world of difference for clinicians. Reimbursement for the use of AI is an area where cardiology is far ahead of most other healthcare specialties.

  • Michael Coords, MD, FSCCT, medical director of cardiovascular imaging at RadNet, explains what the new Maryland law requires when when breast artery calcifications are found in mammograms that indicate the patient may have higher risk of cardiovascular disease.

    Maryland mammography law turns incidental cardiac findings into a new screening opportunity

    The law reflects growing interest in using existing imaging studies to identify cardiovascular disease risk without requiring additional scans, radiation exposure or costs. 

  • HeartMate 3 LVAD abbott

    HeartMate 3 LVAD linked to 16% risk of stroke, other neurological issues—what heart failure specialists should know

    Researchers tracked years of data, noting that strokes and other neurological adverse events reduce a patient's odds of survival.  

  • Video: Rick Snyder, MD, FACC, president of HeartPlace, and Chief Physician Executive at U.S. Heart and Vascular, testified to Congressional leaders in his role with the American Independent Medical Practice Association (AIMPA) to explain how federal healthcare policies have created an inefficient payment system that rewards higher cost care models and is putting lower cost private practices out of business.

    Policy expert explains why cardiology services in the US are getting more expensive

    "We really should have a system that is patient-centric, physician-led, and professionally managed, but in a cost-effective way," Rick Snyder, MD, said.

Thumbnail

Cleveland Clinic's Cremer on cardiac imaging in cardiovascular oncology

At this year's "Nuclear Cardiology Today: Best Practices for Today, Innovation for Tomorrow" conference in Rosemont, Illinois, sponsored by the American Society of Nuclear Cardiology (ASNC), Paul Cremer, MD, discussed the role of cardiac imaging in cardio-oncology.

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

DUBLIN — April 9, 2018 — Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension).

Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015

Medtronic plc (NYSE: MDT) today announced new clinical data in interventional treatments for aortic and peripheral vascular diseases in a late-breaking trial session at Vascular Interventional Advances (VIVA) 2015.

ASNC Releases Dose-Reduction Guidelines for Nuclear Cardiology

Technological improvements in image acquisition and software processing in nuclear cardiology should allow physicians to shave patient imaging times dramatically or cut radiation doses fourfold, according to a new preferred practice statement from the American Society of Nuclear Cardiology (ASNC).

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …204
    • Page 205
    • Page 206
    • Page 207
    • Page 208
    • Page 209
    • Page 210
    • Page 211
    • Current page 212
Displaying 1689 - 1693 of 1693
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme